Barclays’s Everpure Inc P Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.7M Sell
351,101
-94,829
-21% -$6.42M 0.01% 1086
2025
Q4
$29.9M Sell
445,930
-39,529
-8% -$3.3M 0.01% 1026
2025
Q3
$40.7M Buy
485,459
+140,591
+41% +$9.35M 0.01% 872
2025
Q2
$19.9M Buy
344,868
+116,242
+51% +$5.78M ﹤0.01% 1134
2025
Q1
$10.1M Sell
228,626
-263,951
-54% -$15.9M ﹤0.01% 1394
2024
Q4
$30.3M Buy
492,577
+175,666
+55% +$9.78M 0.01% 888
2024
Q3
$15.9M Buy
316,911
+27,345
+9% +$1.55M ﹤0.01% 1189
2024
Q2
$18.6M Sell
289,566
-113,839
-28% -$6.59M 0.01% 965
2024
Q1
$21M Buy
403,405
+216,680
+116% +$9.67M 0.01% 963
2023
Q4
$6.66M Buy
186,725
+5,429
+3% +$190K ﹤0.01% 1860
2023
Q3
$6.46M Sell
181,296
-144,800
-44% -$5.37M ﹤0.01% 1180
2023
Q2
$12M Buy
326,096
+189,714
+139% +$5.37M 0.01% 914
2023
Q1
$3.48M Sell
136,382
-74,523
-35% -$2.01M ﹤0.01% 1790
2022
Q4
$5.64M Buy
210,905
+51,109
+32% +$1.49M ﹤0.01% 1540
2022
Q3
$4.37M Sell
159,796
-83,351
-34% -$2.36M ﹤0.01% 1243
2022
Q2
$6.25M Buy
243,147
+218,250
+877% +$6.04M ﹤0.01% 1219
2022
Q1
$880K Sell
24,897
-46,676
-65% -$1.36M ﹤0.01% 2505
2021
Q4
$2.33M Buy
71,573
+10,657
+17% +$309K ﹤0.01% 2286
2021
Q3
$1.53M Sell
60,916
-167,934
-73% -$3.71M ﹤0.01% 2520
2021
Q2
$4.47M Buy
228,850
+28,229
+14% +$555K ﹤0.01% 1661
2021
Q1
$4.32M Buy
200,621
+171,481
+588% +$4.08M ﹤0.01% 1637
2020
Q4
$658K Buy
29,140
+4,364
+18% +$83.6K ﹤0.01% 3054
2020
Q3
$381K Sell
24,776
-32,306
-57% -$528K ﹤0.01% 3433
2020
Q2
$990K Buy
57,082
+27,122
+91% +$407K ﹤0.01% 2770
2020
Q1
$369K Sell
29,960
-138,302
-82% -$2.24M ﹤0.01% 3829
2019
Q4
$2.88M Buy
168,262
+86,324
+105% +$1.53M ﹤0.01% 2617
2019
Q3
$1.39M Buy
81,938
+12,967
+19% +$203K ﹤0.01% 3317
2019
Q2
$1.05M Sell
68,971
-771,903
-92% -$15.1M ﹤0.01% 3633
2019
Q1
$18.3M Buy
840,874
+774,740
+1,171% +$14.7M 0.01% 897
2018
Q4
$1.06M Sell
66,134
-16,327
-20% -$322K ﹤0.01% 3048
2018
Q3
$2.14M Buy
82,461
+56,508
+218% +$1.4M ﹤0.01% 2797
2018
Q2
$620K Sell
25,953
-21,575
-45% -$474K ﹤0.01% 3746
2018
Q1
$947K Buy
47,528
+9,994
+27% +$196K ﹤0.01% 3282
2017
Q4
$595K Buy
37,534
+29,809
+386% +$497K ﹤0.01% 3624
2017
Q3
$124K Buy
7,725
+6,332
+455% +$86.8K ﹤0.01% 4775
2017
Q2
$17K Sell
1,393
-1,725
-55% -$20.1K ﹤0.01% 5876
2017
Q1
$31K Sell
3,118
-25,990
-89% -$288K ﹤0.01% 5592
2016
Q4
$329K Sell
29,108
-163,254
-85% -$2.12M ﹤0.01% 3756
2016
Q3
$2.61M Buy
192,362
+174,212
+960% +$2.17M ﹤0.01% 1769
2016
Q2
$198K Buy
18,150
+3,850
+27% +$50.2K ﹤0.01% 3927
2016
Q1
$186K Buy
14,300
+1,086
+8% +$14.4K ﹤0.01% 3900
2015
Q4
$198K Buy
+13,214
New +$224K ﹤0.01% 3909

Other funds holding P

Barclays's P Position: Q1 2026 in Review

Barclays reduced its Everpure Inc (P) stake by 21% in Q1 2026, selling an estimated $6.42M and leaving 351,101 shares worth $20.7M. The position accounts for 0.01% of the portfolio, ranked #1086.

Barclays first reported a position in P in Q4 2015 and has held it in 42 quarters since. The position peaked at $40.7M in Q3 2025. 763 funds tracked by Wall St. Rank hold P as of Q1 2026.

  • Barclays held 351,101 shares of Everpure Inc worth $20.7M as of Q1 2026.
  • Barclays sold 94,829 Everpure Inc shares in Q1 2026, an estimated $6.42M.
  • Everpure Inc made up 0.01% of Barclays's portfolio in Q1 2026, its #1086 holding.
  • Barclays first reported a position in Everpure Inc in Q4 2015 and has held it in 42 quarters since.
  • Barclays's Everpure Inc position peaked at $40.7M in Q3 2025.
  • 763 funds tracked by Wall St. Rank held Everpure Inc as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.